Blog

Identifying the right key stakeholders early and including them in the planning offers a greater chance for pharma product launch success.

Patient-reported outcomes (PROs) are a valuable source of information. To unlock the data’s insights, manage it effectively.

Intermediaries in the distribution chain, pharmacy benefit managers (PBMs) play a key role in connecting patients to rare disease treatments.

U.S. personal medical debt tops $140 billion, which has led to a prescription fill rates drop and has worsened patient outcomes.

We connect the dots between time to paid fill and paid fill rate. The longer the time, the less prescriptions are filled.

Why do some patients never fill their prescriptions? Here’s a look at the four main reasons for prescription cancellation.

An Inflation Reduction Act provision intended to boost orphan drug research may have the opposite effect.

Do you have the tools and processes necessary to protect patient data? Here’s what to consider.

Collaborative patient management and care can reduce time to treatment and boost health outcomes for patients.

The Inflation Reduction Act contains provisions that affect drug pricing. Here’s how pharma companies, payers and providers can respond.